A niche blog dedicated to the issues that arise when supplementary protection certificates (SPCs) extend patents beyond their normal life -- and to the respective positions of patent owners, investors, competitors and consumers. The blog also addresses wider issues that may be of interest or use to those involved in the extension of patent rights. You can email The SPC Blog here

Sunday, 8 May 2011

Medeva, Georgetown University hearings

If you're in Luxembourg this coming Thursday, 12 May, and have nothing better to do, why not pop into the Court of Justice of the European Union and check out the hearing in Joined Cases C-322/10 and C-422/10 Medeva and Georgetown University and Others.

Just to remind you, these are references for a preliminary ruling from the Court of Appeal (England and Wales) on the interpretation of Articles 3(a) and (b) of Regulation 469/2009 regarding the meaning of ‘product protected by a basic patent in force’ and whether there exist further or different criteria in respect of a medicinal product comprising more than one active ingredient or for a multi-disease vaccine.


Anonymous said...

Opinion of AG Trstenjak annouced for July 2011

Anonymous said...

Opinion AG Trstenjak 13/07/2011